Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Kidney and Transplant

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Biopsy‐proven CAN (ESW with alemtuzumab only) · kidney transplant recipients

The intervention may leads to higher biopsy‐proven CAN (ESW with alemtuzumab only) (low certainty).

1 finding from 1 review

Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients 2017 · Cochrane Headline outcomes only
RR 2.45 [1.02, 5.94]
2 studies · 86 participants
Low

NODAT (ESW alemtuzumab only) · kidney transplant recipients

The intervention showed no clear difference in NODAT (ESW alemtuzumab only) (low certainty).

1 finding from 1 review

Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients 2017 · Cochrane Headline outcomes only
RR 0.41 [0.12, 1.4]
2 studies · 69 participants
Low